Transcranial Electrical Stimulation in Subacromial Pain Syndrome
Effectiveness of Transcranial Electrical Stimulation in the Functional Recovery of Subjects with Subacromial Pain Syndrome: Randomized Clinical Trial.
1 other identifier
interventional
74
1 country
1
Brief Summary
The goal of this clinical trial is to analyze whether a physiotherapy protocol based on strengthening exercises to the shoulder girdle muscles carried on during anodal transcranial electrical stimulation (a-TES) is more effective on the symptoms and functionality of subjects with subacromial pain syndrome than an isolated strengthening program. The main questions it aims to answer are:
- Is the strengthening + a-TES protocol effective on functionality?
- Is the strengthening + a-TES protocol effective on quality of life?
- Is the strengthening + a-TES protocol effective on pain?
- Is the strengthening + a-TES protocol effective on muscle strength?
- Is the strengthening + a-TES protocol effective on active range of movement?
- Is the strengthening + a-TES protocol effective on proprioception?
- Is the strengthening + a-TES protocol effective on posture?
- Is the strengthening + a-TES protocol effective on glenohumeral and scapulothoracic kinematics? Participants will perform an 8 weeks-3 days/week shoulder strengthening protocol for the rotator cuff and scapulothoracic muscles using elastic bands and dumbbells. The rotator cuff exercises will be performed while they receive a-TES using a neoprene helmet with the electrodes placed in the opposite hemisphere to the affected side. The scapulothoracic exercises will be performed without the transcranial stimulation. The experimental group will receive real a-TES, and will be compared with a control group that will perform the same therapeutic exercises but with placebo a-TES to see the effectiveness of the a-TES on the outcomes cited above.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2023
CompletedFirst Posted
Study publicly available on registry
July 19, 2023
CompletedStudy Start
First participant enrolled
November 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMarch 30, 2025
May 1, 2024
1.9 years
June 29, 2023
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Changes in Pain and disability Index (SPADI), spanish version, scale.
Scale for the measurement of Pain and disability related to shoulder disfunction. It contains 13 items, each with a score on a numerical scale from 0 (best) to 10 (worst). It consists of two domains: pain (of 5 items, score between 0-50) and disability (of 8 items, score between 0-80). In each domain the score can be expressed as a percentage. The total score of the scale is obtained as the sum of both domains (0 -100%). A higher score indicates greater pain-related disability.
Before the intervention, inmediately post intervention (and three months follow up.
Changes in Western Ontario Rotator cuff (WORC), spanish version, scale.
Scale for the measurement of the Quality of life related to shoulder disfunction. It consists of 21 questions, each with a visual analogue scale type response. The questions are grouped into 5 domains or sections: physical symptoms (6 items), sports and recreation (4 items), work (4 items), lifestyle (4 items) and emotions (3 items). Each item is measured on a 100 mm scale (from 0 best to 100 worst). So the worst value is 2100 and the best is 0.
Before the intervention, inmediately post intervention (at eight weeks) and three months follow up.
Changes in a Visual Analogic scale, for the measurement of the shoulder intensity of pain
The intensity of the pain experienced in the affected shoulder at rest, at night and during activity in the last week will be evaluated. For this, a visual analogue scale (VAS) will be used. Subjects will mark pain intensity on a continuous horizontal line 10 cm long, labeled on the left end as "no pain" and on the right as "maximal pain".
Before the intervention, inmediately post intervention (at eight weeks) and three months follow up.
Changes in shoulder pain pressure threshold (PPT) in Kg.
Mechanical sensitivity will be assessed using the Pressure Pain Threshold (PPT), which is defined as the minimum pressure at which the sensation of pressure changes to pain. The PPT will be measured with an analog algometer applied perpendicularly to the skin. The PPT will be evaluated on the affected side on: supraspinatus, infraspinatus, upper trapezius, levator scapulae, middle deltoid, C5-C6 interapophyseal joint and tibialis anterior. Higher PPT values (in Kg) will be interpreted as an improvement in mechanical sensitivity to pain in the tested areas.
Before the intervention, inmediately post intervention (at eight weeks) and three months follow up.
Secondary Outcomes (9)
Changes in shoulder Muscle strenght measured by a dinamometer (Kg)
Before the intervention, inmediately post intervention (at eight weeks) and three months follow up.
Changes in shoulder Active range of movement measured by goniometry (degrees)
Before the intervention, inmediately post intervention (at eight weeks) and three months follow up.
Changes in Joint Position sense measured by the laser-pointer assisted angle reproduction (LP-ART), test (degrees).
Before the intervention, inmediately post intervention (at eight weeks) and three months follow up.
Changes in head forward posture, shoulder protraction and kiphosis (degrees)
Before the intervention, inmediately post intervention (at eight weeks) and three months follow up.
Changes in Subacromial space width measured by ultrasound (milimeters)
Before the intervention, inmediately post intervention (at eight weeks) and three months follow up.
- +4 more secondary outcomes
Study Arms (2)
Strenghtening + a-TES real
EXPERIMENTALProtocol of therapeutic exercises + real transcranial electrical stimulation of 8 weeks duration (24 supervised sessions). The program will consist of exercises to strengthen the RM and the scapulothoracic muscles, but the EG will perform the RM strengthening exercises while receiving real a-tDCS.
Strenghtening + a-TES placebo
SHAM COMPARATORProtocol of therapeutic exercises + placebo transcranial electrical stimulation of 8 weeks duration (24 supervised sessions). The program will consist of exercises to strengthen the RM and the scapulothoracic muscles, but the CG will perform the RM strengthening exercises while receiving placebo a-tDCS.
Interventions
Strenghtening of rotator cuff and scapulothoracic muscles protocol with the incorporation of anodal transcranial direct stimulation (real if experimental or sham if control)
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years.
- Duration of pain greater than or equal to 3 months.
- Presence of 3 or more of the following positive clinical tests:
- painful arc
- External rotation test against isometric resistance
- Neer's test
- Jobe test or empty can test
- Hawkins-Kennedy test
You may not qualify if:
- Previous shoulder or neck surgery.
- History of shoulder fracture or dislocation.
- Medical diagnosis of shoulder osteoarthritis.
- Adhesive capsulitis
- Cervicobrachialgia or reproducible shoulder pain with neck movements.
- Clinical signs of total tear of the rotator cuff.
- Corticosteroid injection in the previous 6 weeks.
- Inflammatory disease, autoimmune or rheumatic, systemic (arthritis, lupus, myopathies).
- Cognitive or behavioral problems that make it impossible to understand and follow the intervention (score less than 24 on the Mini-Mental State Examination Score) (73).
- Any neurological or neoplastic disease.
- Also those who present contraindications for transcranial electrical stimulation. For this, the recommendations of the checklist of Thair et al. which includes:
- personal and family history of epilepsy
- metal implants in the head
- implanted medication pump
- pacemaker
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Valencia
Valencia, Valencia, 46010, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 29, 2023
First Posted
July 19, 2023
Study Start
November 23, 2023
Primary Completion
November 1, 2025
Study Completion
March 1, 2026
Last Updated
March 30, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share